8x60k microarray Search Results


mouse microarray version 3.0 (8 x 60k)  (Arraystar inc)
90
Arraystar inc mouse microarray version 3.0 (8 x 60k)
Mouse Microarray Version 3.0 (8 X 60k), supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8x60k+microarray/pmc08492334__jciinsight___6___150405___s203-20-9-17?v=Arraystar+inc
Average 90 stars, based on 1 article reviews
mouse microarray version 3.0 (8 x 60k) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
agilent sureprint g3 human ge v3 8x60k microarray  (DNA Chip Research Inc)
90
DNA Chip Research Inc agilent sureprint g3 human ge v3 8x60k microarray
Total mutation burden, transcriptome signature (ssGSEA score), and quantitative real‐time polymerase chain reaction analysis of pretreatment melanoma cells and expanded TILs. A, To evaluate their mutation status, exome sequencing was performed on the melanoma cells used for TIL manufacturing. The numbers of mutations and the mutated genes in each tumor are shown in the upper columns. Transcriptome signatures based on single‐sample gene set enrichment analysis (ssGSEA) of the tumor cells are shown in the lower columns. B, ssGSEA scores of gene sets related to tumor phenotype (based on <t>microarray</t> data) in the tumors of the three melanoma patients. The cut‐off score was set at 4,000. C, D, Quantitative RT‐PCR analysis of the expression levels of chemokines in the primary tumors (C) and of cytotoxic factors in the expanded TIL products (D). The results are fold‐changes in gene expression normalized to the endogenous reference gene; error bars are standard deviations
Agilent Sureprint G3 Human Ge V3 8x60k Microarray, supplied by DNA Chip Research Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8x60k+microarray/pmc08353905-72-14-21?v=DNA+Chip+Research+Inc
Average 90 stars, based on 1 article reviews
agilent sureprint g3 human ge v3 8x60k microarray - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
oxford gene 8x60 k array platform cytosure isca v2 design  (Oxford Gene Technology)
90
Oxford Gene Technology oxford gene 8x60 k array platform cytosure isca v2 design
Total mutation burden, transcriptome signature (ssGSEA score), and quantitative real‐time polymerase chain reaction analysis of pretreatment melanoma cells and expanded TILs. A, To evaluate their mutation status, exome sequencing was performed on the melanoma cells used for TIL manufacturing. The numbers of mutations and the mutated genes in each tumor are shown in the upper columns. Transcriptome signatures based on single‐sample gene set enrichment analysis (ssGSEA) of the tumor cells are shown in the lower columns. B, ssGSEA scores of gene sets related to tumor phenotype (based on <t>microarray</t> data) in the tumors of the three melanoma patients. The cut‐off score was set at 4,000. C, D, Quantitative RT‐PCR analysis of the expression levels of chemokines in the primary tumors (C) and of cytotoxic factors in the expanded TIL products (D). The results are fold‐changes in gene expression normalized to the endogenous reference gene; error bars are standard deviations
Oxford Gene 8x60 K Array Platform Cytosure Isca V2 Design, supplied by Oxford Gene Technology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8x60k+microarray/pmc05548528-38-22-19?v=Oxford+Gene+Technology
Average 90 stars, based on 1 article reviews
oxford gene 8x60 k array platform cytosure isca v2 design - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
whole genome oligonucleotide microarrays cytosure constitutional v3 (8x60k)  (microA AS)
90
microA AS whole genome oligonucleotide microarrays cytosure constitutional v3 (8x60k)
Total mutation burden, transcriptome signature (ssGSEA score), and quantitative real‐time polymerase chain reaction analysis of pretreatment melanoma cells and expanded TILs. A, To evaluate their mutation status, exome sequencing was performed on the melanoma cells used for TIL manufacturing. The numbers of mutations and the mutated genes in each tumor are shown in the upper columns. Transcriptome signatures based on single‐sample gene set enrichment analysis (ssGSEA) of the tumor cells are shown in the lower columns. B, ssGSEA scores of gene sets related to tumor phenotype (based on <t>microarray</t> data) in the tumors of the three melanoma patients. The cut‐off score was set at 4,000. C, D, Quantitative RT‐PCR analysis of the expression levels of chemokines in the primary tumors (C) and of cytotoxic factors in the expanded TIL products (D). The results are fold‐changes in gene expression normalized to the endogenous reference gene; error bars are standard deviations
Whole Genome Oligonucleotide Microarrays Cytosure Constitutional V3 (8x60k), supplied by microA AS, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8x60k+microarray/pm37176530-211-17-19?v=microA+AS
Average 90 stars, based on 1 article reviews
whole genome oligonucleotide microarrays cytosure constitutional v3 (8x60k) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
sureprint g3 human ge microarray 8 x 60 k ver3.0 chips  (DNA Chip Research Inc)
90
DNA Chip Research Inc sureprint g3 human ge microarray 8 x 60 k ver3.0 chips
Total mutation burden, transcriptome signature (ssGSEA score), and quantitative real‐time polymerase chain reaction analysis of pretreatment melanoma cells and expanded TILs. A, To evaluate their mutation status, exome sequencing was performed on the melanoma cells used for TIL manufacturing. The numbers of mutations and the mutated genes in each tumor are shown in the upper columns. Transcriptome signatures based on single‐sample gene set enrichment analysis (ssGSEA) of the tumor cells are shown in the lower columns. B, ssGSEA scores of gene sets related to tumor phenotype (based on <t>microarray</t> data) in the tumors of the three melanoma patients. The cut‐off score was set at 4,000. C, D, Quantitative RT‐PCR analysis of the expression levels of chemokines in the primary tumors (C) and of cytotoxic factors in the expanded TIL products (D). The results are fold‐changes in gene expression normalized to the endogenous reference gene; error bars are standard deviations
Sureprint G3 Human Ge Microarray 8 X 60 K Ver3.0 Chips, supplied by DNA Chip Research Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8x60k+microarray/pmc08912548-88-22-6?v=DNA+Chip+Research+Inc
Average 90 stars, based on 1 article reviews
sureprint g3 human ge microarray 8 x 60 k ver3.0 chips - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
agilent human mirna microarray chips (8x60k) v21.0  (Shanghaibio Corp)
90
Shanghaibio Corp agilent human mirna microarray chips (8x60k) v21.0
Total mutation burden, transcriptome signature (ssGSEA score), and quantitative real‐time polymerase chain reaction analysis of pretreatment melanoma cells and expanded TILs. A, To evaluate their mutation status, exome sequencing was performed on the melanoma cells used for TIL manufacturing. The numbers of mutations and the mutated genes in each tumor are shown in the upper columns. Transcriptome signatures based on single‐sample gene set enrichment analysis (ssGSEA) of the tumor cells are shown in the lower columns. B, ssGSEA scores of gene sets related to tumor phenotype (based on <t>microarray</t> data) in the tumors of the three melanoma patients. The cut‐off score was set at 4,000. C, D, Quantitative RT‐PCR analysis of the expression levels of chemokines in the primary tumors (C) and of cytotoxic factors in the expanded TIL products (D). The results are fold‐changes in gene expression normalized to the endogenous reference gene; error bars are standard deviations
Agilent Human Mirna Microarray Chips (8x60k) V21.0, supplied by Shanghaibio Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8x60k+microarray/pm29344634-78-55-61?v=Shanghaibio+Corp
Average 90 stars, based on 1 article reviews
agilent human mirna microarray chips (8x60k) v21.0 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
sureprint g3 human gene expression 8x60k v2 microarray  (IMGM Laboratories GmbH)
90
IMGM Laboratories GmbH sureprint g3 human gene expression 8x60k v2 microarray
Total mutation burden, transcriptome signature (ssGSEA score), and quantitative real‐time polymerase chain reaction analysis of pretreatment melanoma cells and expanded TILs. A, To evaluate their mutation status, exome sequencing was performed on the melanoma cells used for TIL manufacturing. The numbers of mutations and the mutated genes in each tumor are shown in the upper columns. Transcriptome signatures based on single‐sample gene set enrichment analysis (ssGSEA) of the tumor cells are shown in the lower columns. B, ssGSEA scores of gene sets related to tumor phenotype (based on <t>microarray</t> data) in the tumors of the three melanoma patients. The cut‐off score was set at 4,000. C, D, Quantitative RT‐PCR analysis of the expression levels of chemokines in the primary tumors (C) and of cytotoxic factors in the expanded TIL products (D). The results are fold‐changes in gene expression normalized to the endogenous reference gene; error bars are standard deviations
Sureprint G3 Human Gene Expression 8x60k V2 Microarray, supplied by IMGM Laboratories GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8x60k+microarray/pm26776523-250-23-19?v=IMGM+Laboratories+GmbH
Average 90 stars, based on 1 article reviews
sureprint g3 human gene expression 8x60k v2 microarray - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
sureprint g3 human ge 8x60k microarray platform  (BioGenius GmBH)
90
BioGenius GmBH sureprint g3 human ge 8x60k microarray platform
Total mutation burden, transcriptome signature (ssGSEA score), and quantitative real‐time polymerase chain reaction analysis of pretreatment melanoma cells and expanded TILs. A, To evaluate their mutation status, exome sequencing was performed on the melanoma cells used for TIL manufacturing. The numbers of mutations and the mutated genes in each tumor are shown in the upper columns. Transcriptome signatures based on single‐sample gene set enrichment analysis (ssGSEA) of the tumor cells are shown in the lower columns. B, ssGSEA scores of gene sets related to tumor phenotype (based on <t>microarray</t> data) in the tumors of the three melanoma patients. The cut‐off score was set at 4,000. C, D, Quantitative RT‐PCR analysis of the expression levels of chemokines in the primary tumors (C) and of cytotoxic factors in the expanded TIL products (D). The results are fold‐changes in gene expression normalized to the endogenous reference gene; error bars are standard deviations
Sureprint G3 Human Ge 8x60k Microarray Platform, supplied by BioGenius GmBH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/8x60k+microarray/pm31176743-47-22-33?v=BioGenius+GmBH
Average 90 stars, based on 1 article reviews
sureprint g3 human ge 8x60k microarray platform - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Total mutation burden, transcriptome signature (ssGSEA score), and quantitative real‐time polymerase chain reaction analysis of pretreatment melanoma cells and expanded TILs. A, To evaluate their mutation status, exome sequencing was performed on the melanoma cells used for TIL manufacturing. The numbers of mutations and the mutated genes in each tumor are shown in the upper columns. Transcriptome signatures based on single‐sample gene set enrichment analysis (ssGSEA) of the tumor cells are shown in the lower columns. B, ssGSEA scores of gene sets related to tumor phenotype (based on microarray data) in the tumors of the three melanoma patients. The cut‐off score was set at 4,000. C, D, Quantitative RT‐PCR analysis of the expression levels of chemokines in the primary tumors (C) and of cytotoxic factors in the expanded TIL products (D). The results are fold‐changes in gene expression normalized to the endogenous reference gene; error bars are standard deviations

Journal: Cancer Science

Article Title: Adoptive cell therapy using tumor‐infiltrating lymphocytes for melanoma refractory to immune‐checkpoint inhibitors

doi: 10.1111/cas.15009

Figure Lengend Snippet: Total mutation burden, transcriptome signature (ssGSEA score), and quantitative real‐time polymerase chain reaction analysis of pretreatment melanoma cells and expanded TILs. A, To evaluate their mutation status, exome sequencing was performed on the melanoma cells used for TIL manufacturing. The numbers of mutations and the mutated genes in each tumor are shown in the upper columns. Transcriptome signatures based on single‐sample gene set enrichment analysis (ssGSEA) of the tumor cells are shown in the lower columns. B, ssGSEA scores of gene sets related to tumor phenotype (based on microarray data) in the tumors of the three melanoma patients. The cut‐off score was set at 4,000. C, D, Quantitative RT‐PCR analysis of the expression levels of chemokines in the primary tumors (C) and of cytotoxic factors in the expanded TIL products (D). The results are fold‐changes in gene expression normalized to the endogenous reference gene; error bars are standard deviations

Article Snippet: Total RNA from isolated melanoma cells was subjected to microarray analysis using an Agilent SurePrint G3 Human GE v3 8x60K Microarray (DNA Chip Research Inc.).

Techniques: Mutagenesis, Real-time Polymerase Chain Reaction, Sequencing, Microarray, Quantitative RT-PCR, Expressing